Clinical Data, Inc.'s Cogenics Division Successfully Consolidates North Carolina Genomic Labs And Operations

NEWTON, Mass.--(BUSINESS WIRE)--July 27, 2006--Clinical Data, Inc. (NASDAQ: CLDA - News), a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care, announced today that the Company has completed a key step in the consolidation of its North Carolina based genomic labs and offices it acquired as part of the Genaissance and Icoria acquisitions, respectively. As part of this consolidation, Icoria staff and operations previously located in the Company's Research Triangle Park (RTP) facility have been relocated to a Cogenics (formally Genaissance) facility located in Morrisville, North Carolina. The RTP facility was leased space, and the Company has finalized a separation agreement and agreed on a financial settlement to eliminate the ongoing costs associated with this lease. The consolidation move is directly in keeping with the Company's financial and operational objectives to reduce cost and effectively integrate the Cogenics business into the full complement of genomic and genetic testing products and services desired by the division's constituents.

Back to news